Wells Fargo’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310 | Hold |
1,000
| – | – | ﹤0.01% | 5955 |
|
|
2025
Q1 | $421 | Hold |
1,000
| – | – | ﹤0.01% | 5808 |
|
|
2024
Q4 | $701 | Hold |
1,000
| – | – | ﹤0.01% | 5787 |
|
|
2024
Q3 | $469 | Hold |
1,000
| – | – | ﹤0.01% | 5766 |
|
|
2024
Q2 | $1.66K | Buy |
1,000
+854
| +585% | +$1.42K | ﹤0.01% | 5660 |
|
|
2024
Q1 | $266 | Buy |
146
+10
| +7% | +$18 | ﹤0.01% | 6038 |
|
|
2023
Q4 | $252 | Buy |
136
+8
| +6% | +$15 | ﹤0.01% | 6104 |
|
|
2023
Q3 | $184 | Sell |
128
-9
| -7% | -$13 | ﹤0.01% | 6231 |
|
|
2023
Q2 | $251 | Buy |
137
+13
| +10% | +$24 | ﹤0.01% | 6327 |
|
|
2023
Q1 | $246 | Sell |
124
-38,386
| -100% | -$76.2K | ﹤0.01% | 6398 |
|
|
2022
Q4 | $80.9K | Sell |
38,510
-38,417
| -50% | -$80.7K | ﹤0.01% | 4342 |
|
|
2022
Q3 | $146K | Buy |
76,927
+60
| +0.1% | +$114 | ﹤0.01% | 4127 |
|
|
2022
Q2 | $162K | Buy |
76,867
+76,843
| +320,179% | +$162K | ﹤0.01% | 4143 |
|
|
2022
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 6702 |
|
|
2021
Q4 | $0 | Buy |
+24
| New | – | ﹤0.01% | 6687 |
|